Abstract
Low body mass index (BMI) is a well-established risk factor for fracture in postmenopausal women. Height and obesity have also been associated with increased fracture risk at some sites. We investigated the relationships of weight, BMI, and height with incident clinical fracture in a practice-based cohort of postmenopausal women participating in the Global Longitudinal study of Osteoporosis in Women (GLOW). Data were collected at baseline and 1, 2, and 3 years. For hip, spine, wrist, pelvis, rib, upper arm/shoulder, clavicle, ankle, lower leg, and upper leg fractures, we modeled the time to incident self-reported fracture over a 3-year period using the Cox proportional hazards model and fitted the best linear or non-linear models containing height, weight, and BMI. Of 52,939 women, 3628 (6.9%) reported an incident clinical fracture during the 3-year follow-up period. Linear BMI showed a significant inverse association with hip, clinical spine, and wrist fractures: adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) per increase of 5 kg/m2 were 0.80 (0.71–0.90), 0.83 (0.76–0.92), and 0.88 (0.83–0.94), respectively (all p < 0.001). For ankle fractures, linear weight showed a significant positive association: adjusted HR per 5-kg increase 1.05 (1.02–1.07) (p < 0.001). For upper arm/shoulder and clavicle fractures, only linear height was significantly associated: adjusted HRs per 10-cm increase were 0.85 (0.75–0.97) (p = 0.02) and 0.73 (0.57–0.92) (p = 0.009), respectively. For pelvic and rib fractures, the best models were for non-linear BMI or weight (p = 0.05 and 0.03, respectively), with inverse associations at low BMI/body weight and positive associations at high values. These data demonstrate that the relationships between fracture and weight, BMI, and height are site-specific. The different associations may be mediated, at least in part, by effects on bone mineral density, bone structure and geometry, and patterns of falling.
Keywords: FRACTURES, OBESITY, POSTMENOPAUSAL WOMEN, BMI, OSTEOPOROSIS
Introduction
Low body mass index (BMI) is a well-established risk factor for fracture, particularly hip fracture. The relationship between BMI and fracture risk is non-linear, the steepest gradient of risk being seen at BMI values <20 kg/m2 and only a small further decrease in risk being seen at levels >25 kg/m2.(1) Recent data indicate, however, that the association between BMI and fracture risk differs according to fracture site. Thus obesity (BMI ≥ 30 kg/m2) has been associated, in some studies, with increased risk of ankle, upper leg, lower leg, and proximal humerus fracture in postmenopausal women,(2-7) whereas decreased risk of hip, pelvis, and wrist fractures has been reported in comparison with non-obese and underweight women.(2,4,7)
Although the classification of underweight, normal weight, overweight, and obese states is traditionally defined on the basis of BMI, BMI is influenced by both height and weight, each of which may independently contribute to the relationship between BMI and fracture risk. The aim of the present study was to investigate the relationships of weight, BMI, and height with incident clinical fracture in postmenopausal women. We hypothesized that the associations would be site-specific and would be differently influenced by weight/BMI and height.
Materials and Methods
GLOW is a prospective practice-based cohort study involving 723 physician practices at 17 sites in 10 countries (Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Spain, UK, and USA). The study methods have been reported previously.(8) In brief, practices typical of each region were recruited through primary care networks organized for administrative, research, or educational purposes, or by identifying all physicians in a geographic area. Each site obtained local ethics committee approval to participate in the study. The practices provided the names of women aged ≥55 years who had been seen by their physician in the past 24 months. After appropriate exclusions, 60,393 women agreed to participate in the study.
Data collection
Questionnaires were designed to be self-administered and covered domains that included: demographic characteristics and risk factors; fracture history; current medication use; and other medical diagnoses. Data on height and weight were collected at baseline and BMI was calculated as weight (kg) divided by height squared (m2).
Information was collected at baseline on previous self-reported fractures (ie, that had occurred since the age of 45 years), while incident fractures were reported on the 1-, 2-, and 3- year follow-up surveys. All surveys included details of fracture location, including hip, spine, wrist, and other non-vertebral sites (clavicle, upper arm/shoulder, rib, pelvis, ankle, upper leg, lower leg, foot, hand, knee, and elbow), and occurrence of single or multiple fractures. All fractures were self-reported and information on X-ray verification was not available. For the purpose of the present study, fractures of the elbow, feet, and hands were excluded from the analysis. Information was also obtained about comorbid conditions at baseline, including asthma, emphysema, osteoarthritis, rheumatoid arthritis, colitis, stroke, celiac disease, Parkinson’s disease, multiple sclerosis, cancer, type 1 diabetes, hypertension, heart disease, and high cholesterol.
Statistical analysis
For each of 10 fracture sites (hip, spine, wrist, pelvis, rib, upper arm/shoulder, clavicle, ankle, lower leg, upper leg), we modeled the time to incident fracture over the 3-year period using the Cox proportional hazards model and adjusting for variables found to be associated with each specific fracture site, based on previous findings in the same cohort of women.(9) For each fracture site, we considered models containing BMI, height, or weight in three parametric forms: linear, restricted cubic splines, and the best fractional polynomial selected using the closed test procedure as described in Hosmer, Lemeshow, and May.(10) For each fracture site, the best of the nine possible models was chosen as the model with the smallest Akaike Information Criterion (AIC). When the best model was based on restricted cubic splines, we plotted the log-hazard of fracture versus the covariate value to describe the nature of the non-linear relationship between the covariate and the log-hazard of fracture. In the method of restricted cubic spines, three knots or join points were defined to be at the 10th, 50th, and 90th percentiles of the distribution of the variable. Between the minimum value and the 10th percentile, a straight line was used to model the log-hazard. Between the 10th and 50th percentiles and the 50th and 90th percentiles, cubic functions were used. In the last interval, between the 90th percentile and the maximum, a linear model was used. Each of the fits in the four intervals was constrained to join its neighboring fit(s) at the knot. The May and Hosmer goodness-of-fit test(11) was used to assess calibration of each of the fracture type models. All analysis was conducted using SAS software package (SAS Institute, Cary, NC version 9.2).
Results
Demographics of the study population are shown in Table 1. Of the study population of 52,629 women who had completed at least 1-year of follow-up, had weight and height measurements and in whom data on incident fracture were available, 3628 (6.9%) sustained at least one incident clinical fracture during the 3-year follow-up period. The sites of fracture included in the analyses were as follows: hip (n = 309), spine (n = 442), wrist (n = 923), ankle (n = 550), upper arm/shoulder (n = 484), clavicle (n = 133), pelvis (n = 162), rib (n = 536), upper leg (n = 174), and lower leg (n = 234). Women with incident fracture were older and more likely to have a history of fracture (Table 1). Unintentional weight loss of >5 kg was more common in women with incident fracture and self-reported general health was poorer. Self-reported asthma and ulcerative colitis and a history of falls were also more common in women with incident fracture.
Table 1.
Demographics of the Study Population (N = 52,629)
| Variable | No incident fracture (n = 49,001) |
Incident fracture (n = 3628) |
p |
|---|---|---|---|
| Age, years | 68.0 ± 8.5 | 70.8 ± 9.3 | <0.001 |
| BMI, kg/m2 | 26.9 ± 5.7 | 26.6 ± 5.8 | <0.001 |
| Weight, kg | 70.1 ± 15.4 | 69.0 ± 15.7 | <0.001 |
| Height, cm | 161.4 ± 6.8 | 160.9 ± 7.1 | 0.002 |
| Prior fracture | 21.9 | 41.7 | <0.001 |
| Lost >5 kg | 8.9 | 12.7 | <0.001 |
| General health | <0.001 | ||
| Excellent | 9.3 | 6.7 | |
| Very good | 29.6 | 25.1 | |
| Good | 40.2 | 38.6 | |
| Fair | 18.5 | 24.8 | |
| Poor | 2.4 | 4.8 | |
| Physical activity | <0.001 | ||
| Very active | 31.3 | 28.0 | |
| Somewhat active | 46.6 | 44.5 | |
| A little active | 17.9 | 21.3 | |
| Not at all active | 4.2 | 6.2 | |
| Falls | <0.001 | ||
| None | 63.5 | 50.1 | |
| One | 22.5 | 25.5 | |
| Two or more | 14.0 | 24.3 | |
| Asthma | 11.1 | 13.8 | <0.001 |
| Cancer | 14.0 | 16.9 | <0.001 |
| Emphysema | 8.3 | 12.3 | <0.001 |
| High cholesterol | 50.3 | 50.5 | 0.83 |
| Osteoarthritis | 39.4 | 48.4 | <0.001 |
| Ulcerative colitis | 1.9 | 2.9 | <0.001 |
Values are given as mean ± standard deviation or percentage.
BMI = body mass index.
Fracture sites for which linear BMI or weight showed the strongest associations are shown in Table 2. BMI was inversely associated with hip, clinical spine, and wrist fractures, whereas for ankle fractures, the association with weight was positive. The adjusted hazard ratios (HRs) were lower for hip, spine, and wrist fractures for every 5-kg/m2 increase in BMI and higher for ankle fracture for every 5-kg increase in weight (Table 2). Linear weight showed similar, but slightly weaker, associations with hip, spine, and wrist fractures, and linear BMI for ankle fracture. No association was found between height and hip, wrist, or ankle fracture, but the risk of spine fracture was positively related to linear height with an adjusted HR of 1.6 (95% CI, 1.1–2.3) per 10-cm increase.
Table 2.
Fracture Types where the Fitted Model Linear BMI or Linear Weight had the Most Significant Association
| Fracture site |
Best form of BMI/weight/ height |
Adjusted HR (95% CI) |
χ 2 | p | Next best model with different covariate |
χ 2 | p |
|---|---|---|---|---|---|---|---|
| Hipa (n = 309) |
Linear BMI (per 5 kg/m2) |
0.80 (0.71– 0.90) |
14.3 | <0.001 | Linear weight |
12.9 | <0.001 |
| Spineb (n
= 442) |
Linear BMI (per 5 kg/m2) |
0.83 (0.76– 0.92) |
14.5 | 0.0001 | Linear weight |
6.9 | <0.01 |
| Wristc (n
= 923) |
Linear BMI (per 5 kg/m2) |
0.88 (0.83– 0.94) |
16.3 | <0.0001 | Linear weight |
13.4 | <0.001 |
| Ankled (n
= 550) |
Linear weight (per 5 kg) |
1.05 (1.02– 1.07) |
13.9 | <0.001 | Linear BMI | 11.4 | <0.001 |
Adjusted for age, prior hip fracture, falls, unintentional weight loss of >5 kg, and physical activity.
Adjusted for age, prior spine fracture, prior fracture of another bone, unintentional weight loss of >5 kg, asthma, general health, and physical activity.
Adjusted for age, prior wrist fracture, prior fracture of another bone, falls, and osteoarthritis.
Adjusted for age, prior ankle fracture, prior fracture of another bone, falls, emphysema, and cancer.
BMI = body mass index; CI = confidence interval; HR = hazard ratio.
For upper arm/shoulder and clavicle fractures, the best model was for linear height, with an inverse correlation and a reduction in adjusted HR per 10-cm increase in height (Table 3). Neither weight nor BMI were significantly associated with fracture at these sites.
Table 3.
Fracture Types where the Fitted Model Linear in Height had the Most Significant Association
| Fracture site | Best form of BMI/weight/ height |
Adjusted HR (95% CI) |
χ 2 | p | Comments |
|---|---|---|---|---|---|
| Upper arm/shouldera (n = 484) |
Linear height (per 10 cm) |
0.85 (0.75– 0.97) |
5.71 | 0.02 | Neither weight nor BMI were significant in predicting upper arm/shoulder fracture |
| Clavicleb (n = 133) |
Linear height (per 10 cm) |
0.73 (0.57– 0.92) |
6.91 | 0.009 | Neither weight nor BMI were significant in predicting clavicle fracture |
Adjusted for age, prior arm fracture, prior fracture of another bone, falls, and general health.
Adjusted for age, prior clavicle fracture, falls, unintentional weight loss >5 kg, and ulcerative colitis.
BMI = body mass index; CI = confidence interval; HR = hazard ratio.
Table 4 shows the results for pelvic and rib fractures. Non-linear models were best for both sites. For pelvic fractures, BMI was marginally superior to weight; whereas for rib fractures, weight showed the strongest association. Fig. 1 shows that the log-hazard for pelvic fracture decreases sharply from the minimum BMI value of about 13 kg/m2 to the minimum log-hazard at about 30 kg/m2 and then rises gradually. A similar pattern was seen for the log- hazard of rib fracture as a function of weight, the log hazard decreasing to its minimum at a weight of around 80 kg and increasing thereafter. As for pelvic fracture, the curve describing the log hazard was asymmetric about the minimum value, dropping rapidly and then rising gradually.
Table 4.
Fracture Types where the Fitted Model Non-Linear BMI or Non-Linear Weight had the Most Significant Association
| Fracture site |
Best form of BMI/weight/height |
χ 2 | p | Next best model with different covariate |
Comments |
|---|---|---|---|---|---|
| Pelvisa
(n = 162) |
BMI modeled using restricted cubic splines with 3 knotsb |
3.87 | 0.05 | Weight splines | Weight and BMI were similar at predicting pelvis fracture |
| Ribc
(n = 536) |
Weight modeled using restricted cubic splines with 3 knotsb |
4.57 | 0.03 | BMI splines | Weight and BMI were similar at predicting rib fracture |
Adjusted for age, prior pelvis fracture, falls, and high cholesterol.
Knots at the 10th, 50th, and 90th percentiles of the distribution.
Adjusted for age, prior rib fracture, prior fracture of another bone, falls, asthma, and general health.
BMI = body mass index.
Fig. 1.

Log-hazard plot for pelvis fracture by BMI, modeled using restricted cubic spines with three knots at the 10th, 50th, and 90th percentiles of the distribution.
For lower and upper leg fractures, no association was found with weight, BMI, or height using any of the three models.
We assessed the goodness-of-fit of all eight models. For three fractures – hip, rib, and spine – the p-value of the test was <0.05. Further examination of the calibration tables used to compute the test revealed good agreement between the observed and the model-based estimated expected number of fractures in 80% of the groups. As a result, the departure from fit was not deemed sufficiently broad to reject any of the three models. Thus inferences, for all fractures, are based on the described best models.
Discussion
This study provides novel information on the relationships between BMI, weight, and height and fracture risk at multiple fracture sites; and demonstrates that site-specific associations are seen for both BMI/weight and height. For most fracture sites, the relationships were linear, but for rib and pelvic fracture, a non-linear relationship was seen with increased fracture risk at both extremes of BMI and weight, although risk was much greater at lower BMIs.
Recent studies comparing fracture incidence in obese and non-obese individuals have demonstrated that obesity, defined on the basis of BMI, is associated with increased risk of fracture at some sites but is protective at others. Reduced risk of hip fracture in obese postmenopausal women compared with non-obese women has been a consistent finding,(2,4,7) and a lower incidence of wrist fracture in obese compared with non-obese women has also been reported.(4) Conversely, obesity has been associated with an increased risk of ankle and other leg fractures (excluding hip)(3,4,6) and an increased risk of proximal humerus fracture.(5,7) The results of such studies are influenced to some extent by the distribution of BMI in the population studied; for example, in cohorts with a low prevalence of obesity, a predilection for certain fracture sites in obese individuals becomes difficult to detect, whereas in populations with a high prevalence of obesity, previously unreported associations may emerge. Additionally, the design of such studies does not enable examination of the nature of the relationship between fracture and BMI, weight, or height over the whole range of values.
Studies of the relationship between spine fractures and BMI/weight have produced conflicting data. In two cross-sectional studies, a positive association between BMI and prevalent morphometric vertebral fractures has been reported in postmenopausal women,(12,13) whereas in the present study, BMI and weight were inversely related to clinical incident vertebral fractures. Prieto-Alhambra et al.(7) did not observe differences in clinical spine fracture incidence between obese and non-obese postmenopausal women, although in men, obesity was associated with a significantly reduced risk of clinical spine fracture. The reasons for these contrasting findings are unclear, but may reflect the differences in BMI distribution in the populations, as discussed above, as well as variations in the criteria for diagnosis of vertebral fracture.
A number of mechanisms whereby BMI/weight may influence fracture risk have been proposed.(14) These include effects on bone mineral density; muscle strength; the frequency, direction, and impact of falls, with greater biomechanical forces resulting from higher body weight; the protective response to falling; and the presence or absence of soft tissue padding. In addition, increased cytokine production by visceral fat, altered insulin homeostasis, and higher prevalence of vitamin D insufficiency in obese individuals may be implicated.(15-27)
Taller body height has been reported by several groups to be a risk factor for hip and wrist fracture in postmenopausal women,(28-36) and in one study, height at the age of 25 years was also positively correlated with vertebral fracture prevalence.(31) In the present study, we found a positive association between height and spine fracture, but not hip or wrist fracture, whilst an inverse relationship was observed between height and clavicular and upper arm/shoulder fractures. Mechanisms by which greater height may increase fracture risk include greater impact of falling, greater cortical porosity,(29) and, for hip fracture, greater hip axis length. The reason why smaller height is associated with clavicle and upper arm fractures is unclear. Greater risk might be expected in taller people because of a greater impact of falling; in addition, there is evidence that cortical thickness relative to bone size is reduced in taller people and that cortical porosity is increased.(29) However, the wider bones in taller people may offset the potentially adverse effects of these changes in cortical structure, and the narrower bones in smaller people might thus be more prone to fracture.
Previous studies investigating the relationship between BMI/weight and fracture have not specifically examined the relationship between BMI and weight and pelvic and rib fractures and our study is the first to demonstrate that this relationship is non-linear for these fractures. Lower risk of pelvis fractures has been reported in obese compared with non-obese postmenopausal women;(4) however, our data indicate that increased risk is seen at both extremes of BMI and weight. Associations between BMI and rib fractures have not been reported in postmenopausal women, although in a recent study, a significantly higher risk of multiple rib fractures was reported in obese men when compared with normal or underweight men.(37)
Strengths and limitations
Our study has several strengths, including the large sample size, prospective design, and international scope. There are also, however, some limitations. GLOW is a practice-based rather than a population-based study and is therefore subject to bias both in the selection of physicians and in the sampling and recruitment of patients. All data were collected by patient self-report and may be limited by recall bias and measurement error with regard to reported height and weight. Studies that have examined the validity of self-reported fractures have shown reasonable accuracy,(38,39) although this may be less true for rib fractures, which are seldom verified radiologically. However, there is no reason why accuracy of reporting of any fractures should differ according to BMI. We therefore believe that the generalizability of our findings to clinical practice in the general population is likely to be good, but cannot exclude possible effects of sampling bias and inaccuracies resulting from self-report of fractures. Finally, only women were included in the study, and relationships between fracture and BMI, weight, and height may be different in men.
In conclusion, our results in this large cohort of postmenopausal women demonstrate that associations between fracture risk and height, weight, and BMI differ according to fracture site. Inverse linear associations between BMI or weight and hip, spine, and wrist fracture were observed, whilst a positive linear association was seen with ankle fracture. A positive association was also seen between height and spine fracture. Upper arm/shoulder and clavicle fractures were not associated with BMI or weight, but were inversely associated with height, and non-linear associations with BMI and weight were seen for pelvis and rib fractures. No significant associations were seen between height, weight, or BMI and lower or upper leg fractures. In view of the rapidly rising incidence of obesity in many parts of the world,(40-43) our results have implications for the epidemiology of fractures in elderly populations and suggest that, in the future, changes may emerge in the distribution of fractures at different skeletal sites.
Acknowledgements
Sophie Rushton-Smith, PhD, coordinated revisions and provided editorial assistance, including editing, checking content and language, formatting, and referencing.
Grants: Financial support for the GLOW study is provided by Warner Chilcott Company, LLC and sanofi-aventis to the Center for Outcomes Research, University of Massachusetts Medical School. JEC acknowledges support from the Cambridge Biomedical Research Centre and the National Institute for Health Research (NIHR).
Footnotes
Supplemental data: None.
Disclosures
JEC has previously consulted for Servier, Shire, Nycomed, Novartis, Amgen, Procter & Gamble, Wyeth, Pfizer, The Alliance for Better Bone Health, Roche and GlaxoSmithKline; has received lecture fees, travel and accommodation from Servier, Procter & Gamble and Lilly; and has received grant support from Nycomed (2009–2012) and Acuitas (2009–2011). JF, DH, and JWN state that they have no conflicts of interest. NBW has received honoraria for lectures during the past year from Amgen, Lilly, Novartis and Warner Chilcott; consulting fees during the past year from Abbott, Amgen, Bristol-Myers Squibb, Endo, Imagepace, Johnson & Johnson, Lilly, Medpace, Merck, Nitto Denko, Noven, Novo Nordisk, Pfizer/Wyeth and Quark; research support (through his Health System) from Merck and NPS; and cofounded, has stock options in and is a director of OsteoDynamics. ESS has previously consulted for Amgen, Lilly, Novartis, Merck and Pfizer; and has served on Speakers’ Bureaus for Amgen and Lilly. SS has received grant support from Wyeth, Lilly, Novartis and Alliance; has served on Speakers’ Bureaus for Lilly, Novartis, Pfizer and Procter & Gamble; has received honoraria from Procter & Gamble; and has previously consulted/acted as an Advisory Board member for Lilly, Argen, Wyeth, Merck, Roche and Novartis. KGS has consulted for or received other remuneration from Merck, Amgen and Eli Lilly; has received research grants from Merck; and has held non-remunerative positions of influence on the NOF Board of Trustees and as ACR Chair on the Quality of Care Committee. CR has received honoraria from and consults/acts as an advisory board member for Alliance, Amgen, Lilly, Merck, Novartis, Nycomed, Roche, GlaxoSmithKline, Servier and Wyeth. MR is on the Speakers’ Bureau for Roche. JP has received grant support from Amgen, Kyphon, Novartis and Roche; has received grant support for equipment from GE Lunar; has served on Speakers’ Bureaus for Amgen, sanofi-aventis, GlaxoSmithKline, Roche, Lilly Deutschland, Orion Pharma, Merck, Merckle, Nycomed and Procter & Gamble; and has acted as an Advisory Board member for Novartis, Roche, Procter & Gamble and Teva. JCN has previously consulted for Roche Diagnostics, Daiichi-Sankyo, Proctor & Gamble and Nycomed; has received lecture fees, travel and accommodation from E. Lilly, Amgen, Novartis and Will Farma and has received grant support from The Alliance for Better Bone Health and Amgen. LM has acted as an Advisory Board member for Servier and received speakers’ bureau fees and support to travel to scientific meetings from Servier, Merk and Pfizer. AZL has received funding from The Alliance for Better Bone Health (sanofi-aventis and Warner Chilcott) and is an Advisory Board member for Amgen. FHH, SHG, and FAA have received funding from Pfizer. SLG has previously consulted/been an Advisory Board member for Amgen, Lilly and Merck; and has received grant support from The Alliance for Better Bone Health (sanofi-aventis and Proctor & Gamble) and Lilly. AD-P has received consulting fees and lectured for Eli Lilly, Amgen, Procter & Gamble, Servier and Daiichi-Sankyo; has been an expert witness for Merck; consults for/is an Advisory Board member for Novartis, Eli Lilly, Amgen and Procter & Gamble; has received honoraria from Novartis, Lilly, Amgen, Procter & Gamble and Roche; has previously been an expert witness for Merck; and has previously consulted/acted as an Advisory Board member for Novartis, Lilly, Amgen and Procter & Gamble. CC has previously consulted for/received lecture fees from Amgen, The Alliance for Better Bone Health (sanofi-aventis and Warner Chilcott), Lilly, Merck, Servier, Novartis and Roche-GSK. RDC has received funding from the French Ministry of Health, Merck, Servier, Lilly and Procter & Gamble; has received honoraria from Amgen, Servier, Novartis, Lilly, Roche and sanofi-aventis; and has previously consulted/acted as an Advisory Board member for Amgen, Merck, Servier, Nycomed and Novartis. SB has received grant support from Amgen, Lilly, Novartis, Pfizer, Procter & Gamble, sanofi-aventis, Roche and GlaxoSmithKline; and has received honoraria from, served on Speakers’ Bureaus for and previously consulted/acted as an Advisory Board member for Amgen, Lilly, Merck, Novartis, Procter & Gamble, sanofi-aventis and Servier. SA has received honoraria for boards and speeches from Merck, Eli-Lilly, Amgen. JDA has received consulting fees or other remuneration from Amgen, Eli Lilly, Merck, Novartis, Warner Chilcott; has received research grants from Amgen, Eli Lilly, Merck, and Novartis; has held a non-remunerative position of influence on the IOF Board of Directors, Osteoporosis Canada; and has been on speakers bureaus for Amgen, Eli Lilly, Merck, Novartis and Warner Chilcott.
Authors’ roles: Study design: JEC, NBW, ESS, SS, KGS, CR, JP, JWN, JCN, LM, AZL, FHH, SLG, SHG, ADP, CC, RDC, SB, FAA, SA, JDA. Study conduct: JEC, NBW, ESS, SS, KGS, CR, MR, JP, JWN, JCN, LM, AZL, FHH, SLG, SHG, ADP, CC, RDC, SB, FAA, SA, JDA. Data collection: NBW, SS, KGS, CR, MR, JP, JWN, JCN, LM, AZL, SHG, ADP, CC, RDC, SB, SA, JDA. Data analysis: JF and DWH. Data interpretation: JEC. Drafting manuscript: JEC. Revising manuscript content: JEC, JF, DWH, NBW, ESS, SS, KGS, CR, MR, JP, JWN, JCN, LM, AZL, FHH, SLG, SHG, ADP, CC, RDC, SB, FAA, SA, JDA. Approving final version of manuscript: JEC, JF, DWH, NBW, ESS, SS, KGS, CR, MR, JP, JWN, JCN, LM, AZL, FHH, SLG, SHG, ADP, CC, RDC, SB, FAA, SA, and JDA. JEC, JF and DWH take responsibility for the integrity of the data analysis.
References
- 1.De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ, 3rd, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16(11):1330–1338. doi: 10.1007/s00198-005-1863-y. [DOI] [PubMed] [Google Scholar]
- 2.Armstrong ME, Spencer EA, Cairns BJ, Banks E, Pirie K, Green J, Wright FL, Reeves GK, Beral V, Million Women Study Collaborators Body mass index and physical activity in relation to the incidence of hip fracture in postmenopausal women. J Bone Miner Res. 2011;26(6):1330–1338. doi: 10.1002/jbmr.315. [DOI] [PubMed] [Google Scholar]
- 3.Bergkvist D, Hekmat K, Svensson T, Dahlberg L. Obesity in orthopedic patients. Surg Obes Relat Dis. 2009;5(6):670–672. doi: 10.1016/j.soard.2009.05.014. [DOI] [PubMed] [Google Scholar]
- 4.Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, Pfeilschifter J, Silverman S, Diez-Perez A, Lindsay R, Saag KG, Netelenbos JC, Gehlbach S, Hooven FH, Flahive J, Adachi JD, Rossini M, Lacroix AZ, Roux C, Sambrook PN, Siris ES, GLOW Investigators Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med. 2011;124(11):1043–1050. doi: 10.1016/j.amjmed.2011.06.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gnudi S, Sitta E, Lisi L. Relationship of body mass index with main limb fragility fractures in postmenopausal women. J Bone Miner Metab. 2009;27(4):479–484. doi: 10.1007/s00774-009-0056-8. [DOI] [PubMed] [Google Scholar]
- 6.King CM, Hamilton GA, Cobb M, Carpenter D, Ford LA. Association between ankle fractures and obesity. J Foot Ankle Surg. 2012;51(5):543–547. doi: 10.1053/j.jfas.2012.05.016. [DOI] [PubMed] [Google Scholar]
- 7.Prieto-Alhambra D, Premaor MO, Fina Aviles F, Hermosilla E, Martinez-Laguna D, Carbonell-Abella C, Nogues X, Compston JE, Diez-Perez A. The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res. 2012;27(2):294–300. doi: 10.1002/jbmr.1466. [DOI] [PubMed] [Google Scholar]
- 8.Hooven FH, Adachi JD, Adami S, Boonen S, Compston J, Cooper C, Delmas P, Diez-Perez A, Gehlbach S, Greenspan SL, LaCroix A, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris E, Watts NB, Anderson FA., Jr. The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int. 2009;20(7):1107–1116. doi: 10.1007/s00198-009-0958-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.FitzGerald G, Boonen S, Compston JE, Pfeilschifter J, LaCroix AZ, Hosmer DW, Jr., Hooven FH, Gehlbach SH, GLOW Investigators Differing risk profiles for individual fracture sites: evidence from the Global Longitudinal Study of Osteoporosis in Women (GLOW) J Bone Miner Res. 2012;27(9):1907–1915. doi: 10.1002/jbmr.1652. [DOI] [PubMed] [Google Scholar]
- 10.Hosmer DW, Jr., Lemeshow S, May S. Applied Survival Analysis: Regression Modeling of Time to Event Data. Second Wiley-Blackwell; Hoboken, NJ: 2008. [Google Scholar]
- 11.May S, Hosmer DW. A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal. 1998;4(2):109–120. doi: 10.1023/a:1009612305785. [DOI] [PubMed] [Google Scholar]
- 12.Laslett LL, Just Nee Foley SJ, Quinn SJ, Winzenberg TM, Jones G. Excess body fat is associated with higher risk of vertebral deformities in older women but not in men: a cross-sectional study. Osteoporos Int. 2012;23(1):67–74. doi: 10.1007/s00198-011-1741-8. [DOI] [PubMed] [Google Scholar]
- 13.Pirro M, Fabbriciani G, Leli C, Callarelli L, Manfredelli MR, Fioroni C, Mannarino MR, Scarponi AM, Mannarino E. High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab. 2010;28(1):88–93. doi: 10.1007/s00774-009-0108-0. [DOI] [PubMed] [Google Scholar]
- 14.Compston J. Obesity and bone. Curr Osteoporos Rep. 2013;11(1):30–35. doi: 10.1007/s11914-012-0127-y. [DOI] [PubMed] [Google Scholar]
- 15.Amati F, Pennant M, Azuma K, Dube JJ, Toledo FG, Rossi AP, Kelley DE, Goodpaster BH. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity (Silver Spring) 2012;20(5):1115–1117. doi: 10.1038/oby.2011.401. [DOI] [PubMed] [Google Scholar]
- 16.Barbour KE, Zmuda JM, Boudreau R, Strotmeyer ES, Horwitz MJ, Evans RW, Kanaya AM, Harris TB, Bauer DC, Cauley JA. Adipokines and the risk of fracture in older adults. J Bone Miner Res. 2011;26(7):1568–1576. doi: 10.1002/jbmr.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Barbour KE, Zmuda JM, Boudreau R, Strotmeyer ES, Horwitz MJ, Evans RW, Kanaya AM, Harris TB, Cauley JA, Health ABC Study The effects of adiponectin and leptin on changes in bone mineral density. Osteoporos Int. 2012;23(6):1699–1710. doi: 10.1007/s00198-011-1768-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone. 2006;38(3):317–321. doi: 10.1016/j.bone.2005.08.018. [DOI] [PubMed] [Google Scholar]
- 19.Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Harrington LM, Breggia A, Rosen CJ, Miller KK. Determinants of bone mineral density in obese premenopausal women. Bone. 2011;48(4):748–754. doi: 10.1016/j.bone.2010.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Rosen CJ, Klibanski A, Miller KK. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) 2011;19(1):49–53. doi: 10.1038/oby.2010.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res. 2011;6:30. doi: 10.1186/1749-799X-6-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab. 2009;94(9):3387–3393. doi: 10.1210/jc.2008-2422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D, Fulford AD, Perkins SM, Considine RV, Peacock M. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011;96(5):1320–1326. doi: 10.1210/jc.2010-2202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lecka-Czernik B, Rosen CJ, Kawai M. Skeletal aging and the adipocyte program: New insights from an "old" molecule. Cell Cycle. 2010;9(18):3648–3654. doi: 10.4161/cc.9.18.13046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Napoli N, Pedone C, Pozzilli P, Lauretani F, Ferrucci L, Incalzi RA. Adiponectin and bone mass density: The InCHIANTI study. Bone. 2010;47(6):1001–1005. doi: 10.1016/j.bone.2010.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rosen CJ, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med. 2009;122(5):409–414. doi: 10.1016/j.amjmed.2008.11.027. [DOI] [PubMed] [Google Scholar]
- 27.Russell M, Mendes N, Miller KK, Rosen CJ, Lee H, Klibanski A, Misra M. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010;95(3):1247–1255. doi: 10.1210/jc.2009-1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Benetou V, Orfanos P, Benetos IS, Pala V, Evangelista A, Frasca G, Giurdanella MC, Peeters PH, van der Schouw IT, Rohrmann S, Linseisen J, Boeing H, Weikert C, Pettersson U, Van Guelpen B, Bueno de Mesquita HB, Altzibar J, Boffetta P, Trichopoulou A. Anthropometry, physical activity and hip fractures in the elderly. Injury. 2011;42(2):188–193. doi: 10.1016/j.injury.2010.08.022. [DOI] [PubMed] [Google Scholar]
- 29.Bjornerem A, Bui Q, Ghasem-Zadeh A, Hopper J, Zebaze R, Seeman E. Fracture risk and height: An association partly accounted for by cortical porosity of relatively thinner cortices. J Bone Miner Res. 2013 doi: 10.1002/jbmr.1934. Epub ahead of print. [DOI] [PubMed] [Google Scholar]
- 30.Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM, Study of Osteoporotic Fractures Research Group Risk factors for hip fracture in white women. N Engl J Med. 1995;332(12):767–773. doi: 10.1056/NEJM199503233321202. [DOI] [PubMed] [Google Scholar]
- 31.Gunnes M, Lehmann EH, Mellstrom D, Johnell O. The relationship between anthropometric measurements and fractures in women. Bone. 1996;19(4):407–413. doi: 10.1016/s8756-3282(96)00196-2. [DOI] [PubMed] [Google Scholar]
- 32.Hemenway D, Feskanich D, Colditz GA. Body height and hip fracture: a cohort study of 90,000 women. Int J Epidemiol. 1995;24(4):783–786. doi: 10.1093/ije/24.4.783. [DOI] [PubMed] [Google Scholar]
- 33.Joakimsen RM, Fonnebo V, Magnus JH, Tollan A, Sogaard AJ. The Tromsø Study: body height, body mass index and fractures. Osteoporos Int. 1998;8(5):436–442. doi: 10.1007/s001980050088. [DOI] [PubMed] [Google Scholar]
- 34.Meyer HE, Tverdal A, Falch JA. Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol. 1993;137(11):1203–1211. doi: 10.1093/oxfordjournals.aje.a116622. [DOI] [PubMed] [Google Scholar]
- 35.Meyer HE, Tverdal A, Falch JA. Body height, body mass index, and fatal hip fractures: 16 years' follow-up of 674,000 Norwegian women and men. Epidemiology. 1995;6(3):299–305. [PubMed] [Google Scholar]
- 36.Nevitt MC, Cummings SR, The Study of Osteoporotic Fractures Research Group Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. J Am Geriatr Soc. 1993;41(11):1226–1234. doi: 10.1111/j.1532-5415.1993.tb07307.x. [DOI] [PubMed] [Google Scholar]
- 37.Premaor MO, Compston JE, Aviles FF, Pages-Castella A, Nogues X, Diez-Perez A, Prieto-Alhambra D. The association between fracture site and obesity in men: A population-based cohort study. J Bone Miner Res. 2013 doi: 10.1002/jbmr.1878. Epub ahead of. [DOI] [PubMed] [Google Scholar]
- 38.Ismail AA, O'Neill TW, Cockerill W, Finn JD, Cannata JB, Hoszowski K, Johnell O, Matthis C, Raspe H, Raspe A, Reeve J, Silman AJ, European Prospective Osteoporosis Study Group Validity of self-report of fractures: results from a prospective study in men and women across Europe. Osteoporos Int. 2000;11(3):248–254. doi: 10.1007/s001980050288. [DOI] [PubMed] [Google Scholar]
- 39.Ivers RQ, Cumming RG, Mitchell P, Peduto AJ. The accuracy of self-reported fractures in older people. J Clin Epidemiol. 2002;55(5):452–457. doi: 10.1016/s0895-4356(01)00518-2. [DOI] [PubMed] [Google Scholar]
- 40.Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–567. doi: 10.1016/S0140-6736(10)62037-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–497. doi: 10.1001/jama.2012.39. [DOI] [PubMed] [Google Scholar]
- 42.Haby MM, Markwick A, Peeters A, Shaw J, Vos T. Future predictions of body mass index and overweight prevalence in Australia, 2005–2025. Health Promot Int. 2012;27(2):250–260. doi: 10.1093/heapro/dar036. [DOI] [PubMed] [Google Scholar]
- 43.Ramachandran A, Snehalatha C. Rising burden of obesity in Asia. J Obes. 2010 doi: 10.1155/2010/868573. 2010. Article ID 868573. [DOI] [PMC free article] [PubMed] [Google Scholar]
